ArticleJournal of clinical tuberculosis and other mycobacterial diseases2026
Evolution of evidence on vitamin D supplementation in tuberculosis: A comprehensive umbrella review of nine systematic reviews.
Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vitamin D supplementation as adjunctive therapy in tuberculosis has generated multiple systematic reviews with variable conclusions. The proliferation of syntheses in this field requires comprehensive evaluation to determine the temporal evolution of evidence and its translation into clinical recommendations. Objective: To synthesize systematic reviews on vitamin D supplementation in tuberculosis, evaluate the temporal evolution of conclusions, examine heterogeneity in clinical outcomes, and determine the quality of available evidence for clinical practice. Methods: An umbrella review was conducted in accordance with PRIOR guidance for overviews of reviews, searching MEDLINE, Embase, Web of Science, and Scopus. Systematic reviews examining vitamin D as adjunctive therapy in tuberculosis were included. Methodological quality was assessed using AMSTAR-2 and ROBIS, and evidence certainty was evaluated with GRADE adapted for umbrella reviews. Overlap among primary randomized trials was quantified using a citation matrix and the corrected covered area (CCA). Results: Nine systematic reviews (2009-2022) were identified, encompassing 300-2991 participants. A citation matrix identified 16 unique primary RCTs and 64 trial occurrences across nine reviews, corresponding to very high overlap (CCA = 37.5%). Meta-analytic findings consistently demonstrated null effects for primary outcomes: culture conversion RR 1.04-1.05, time to conversion HR 1.04-1.15, and mortality without significant differences. Subgroup analyses revealed potential effects in VDR TaqI tt genotype (HR 8.09, 95% CI 1.36-48.01) and multidrug-resistant tuberculosis (RR 2.40, 95% CI 1.11-5.18), although these findings were based on small sample sizes. Safety profiles were favorable with hypercalcemia <2%. Conclusions: Current evidence from overlapping systematic reviews does not support routine vitamin D supplementation as adjunctive therapy to improve tuberculosis treatment outcomes in unselected populations. Signals in VDR TaqI tt genotype carriers and multidrug-resistant tuberculosis remain hypothesis-generating and require prospective validation before clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.